Please join Dr. Amy Clippinger and Dr. Andreas Stucki as they share their experience with New Approach Methods and regulatory testing; walking us through their case study on Respiratory Toxicity. What you’ll learn: To gain confidence in new approach methodologies (NAMs) for predicting human health effects, it is essential to focus on the relevance of the test system to human …
In this webinar, Pamela Bachour El Azzi, PhD discussed the different applications of HepaRG cells: induction studies, DILI (cholestasis, steatosis) and the 3D systems.What you’ll learn: Coverage of key information about HepaRG cell model and its benefits The use of HepaRG cells for CYP induction and hepatotoxicity studies HepaRG cell engineering and modes of culture All registered participants will receive …
We just showcased our new Chief Scientific Officer, Leslie Recio, PhD, DABTin our May 10th webinar. Les discussed integrating traditional genetic toxicology endpoints with genomic profiling to assess genotoxicity in the HepaRG™ cell platform. He furthere explained how high throughput comet assay using CometChip® technology, a single cell array platform developed at MIT, flow cytometry-based micronucleus (MN) assay, and toxicogenomics …